If a trauma patient has uncontrolled bleeding, the therapeutic priority is to stop the bleeding as quickly as possible. However, a patient may have hard-to-diagnose, life-threatening condition called trauma-induced coagulopathy (TIC) that can increase blood loss. A team led by Nathan Sniadecki in the UW Department...
The Institute of Translational Health Sciences has reopened its Gene and Cell Therapy Lab. As a biologic manufacturing facility designed to support Phase I/II clinical trials, the lab recently redesigned its operations to address the unique requirements for novel gene and cell therapy products. Located within...
In the world of drug development, researchers may experience many false starts and tests before a compound successfully makes it through clinical trials and enters the market. In fact, approximately 1 in 12 treatments ever make it to patients. What happens to promising molecular compounds...
If you've been the recipient of ITHS resources, please mention us in your publication, press release, or presentation. Just copy and paste our pre-written text into your document. We’ve included the basic guidelines below. Thank you for your cooperation in acknowledging our support of your work. Example...
Kathleen Myers, MD, MPH wants to help support families with a child who is struggling with mental or behavioral health problems, especially families who live far from the offices of a child and adolescent psychiatrist. From her position at Seattle Children’s Hospital, Myers has been involved in...
For pharmaceutical researcher Rodney Ho, there was a flash of an idea and then a journey of a thousand small steps to get it from the laboratory to patients. One of those integral steps was a pilot grant from ITHS for testing a device in...
When you meet Tueng Shen, who is both a medical doctor seeing patients and a researcher and engineer, she makes you comfortable right away. She uses her own story of straddling cultures to illustrate a special strength of the translational sciences world, where she feels her...
The life of a researcher includes many promising paths that have twists and turns. Oliver Press, MD, PhD, has spent more than 20 years exploring the oncology of blood cancers. He has multiple awards already for progress he has made in treatment of patients with lymphomas, one of...